felodipine has been researched along with Atherogenesis in 4 studies
Felodipine: A dihydropyridine calcium antagonist with positive inotropic effects. It lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels.
felodipine : The mixed (methyl, ethyl) diester of 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid. A calcium-channel blocker, it lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels. It is used in the management of hypertension and angina pectoris.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The positive rates of NF-kappaB in both atherosclerosis model group and felodipine treating group (46." | 7.75 | [Effect of felodipine on the expression of NF-kappaB in rat model of atherosclerosis]. ( Cao, Y; Du, XD; Nie, H; Zhang, S, 2009) |
| "The positive rates of NF-kappaB in both atherosclerosis model group and felodipine treating group (46." | 3.75 | [Effect of felodipine on the expression of NF-kappaB in rat model of atherosclerosis]. ( Cao, Y; Du, XD; Nie, H; Zhang, S, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, XD | 1 |
| Zhang, S | 1 |
| Cao, Y | 1 |
| Nie, H | 1 |
| Fomin, VV | 1 |
| Wassmann, K | 1 |
| Ghiassi, A | 1 |
| Wassmann, S | 1 |
| Böhm, M | 1 |
| Nickenig, G | 1 |
| Yao, R | 1 |
| Cheng, X | 1 |
| Liao, YH | 1 |
| Chen, Y | 1 |
| Xie, JJ | 1 |
| Yu, X | 1 |
| Ding, YJ | 1 |
| Tang, TT | 1 |
1 review available for felodipine and Atherogenesis
| Article | Year |
|---|---|
[Calcium antagonists: on the way to expanding the indications].
Topics: Atherosclerosis; Calcium; Calcium Channel Blockers; Chronic Disease; Felodipine; Humans; Hypertensio | 2010 |
1 trial available for felodipine and Atherogenesis
| Article | Year |
|---|---|
AT1 receptor antagonism improves endothelial dysfunction in postmenopausal women.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Atherosclerosis; Benzimidazoles; Biphenyl Compounds; | 2006 |
2 other studies available for felodipine and Atherogenesis
| Article | Year |
|---|---|
[Effect of felodipine on the expression of NF-kappaB in rat model of atherosclerosis].
Topics: Animals; Aorta; Atherosclerosis; Calcium Channel Blockers; Dietary Fats; Felodipine; Male; NF-kappa | 2009 |
Molecular mechanisms of felodipine suppressing atherosclerosis in high-cholesterol-diet apolipoprotein E-knockout mice.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Blood Pressure; Calcium Channel Blockers; Chemokine CCL | 2008 |